$0.81 12.5%
Price vs. AI Score (Last 150 days)
Data gathered: December 6

Data Bits

Data Bits Value / Change Benchmark
Job Posts 9 0%
Sentiment 75 0%
Webpage traffic 10,000 -20.6%
Employee Rating 70 0%
Google Adspend $ N/A N/A
Google Trends 55 19.6%
Linkedin Employees 492 N/A
Patents 128 0%
4chan Mentions 0% N/A
Facebook Engagement 0% N/A
Facebook followers 1,210 0% N/A
Stocktwits Mentions 55 -26.7%
Stocktwits Subscribers 30,997 0%
Twitter Followers 2,190 0%
News Mentions 0%
Reddit Mentions 0%
Business outlook 23 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About Amarin

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid.

Price $0.81
Target Price Sign up
Market Cap $294M
Dividend Yield 0.0212
Industry Biotechnology

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '2366M70M30M-19M-21M
Q2 '2380M84M43M-18M-23M
Q1 '2386M86M48M-16M-17M
Q4 '2290M95M64M860,000-9M
Q3 '2290M86M63M-5.1M-4.5M

Insider Transactions

Holt Patrick filed to buy 300,000 shares at $1.1.
August 16 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.